Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer
Clinical trial NCT02467907 · COMPLETED
Trial details
- NCT number
- NCT02467907
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-28
- Primary completion
- 2018-12-31
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.